Navigation Links
Volcano Announces First Quarter Results
Date:5/2/2013

nd the company's reaction to those factors; purchasing decisions with respect to the company's products; the pace and extent of market adoption of the company's products and technologies; uncertainty in the process obtaining regulatory approval or clearance for Volcano's products or devices; the success of Volcano's growth and other strategies including integration of recently-acquired businesses and our ability to integrate businesses from future acquisitions; risks associated with Volcano's international operations; timing and achievement of product development milestones; outcome of ongoing or future litigation; investigations and claims; the impact and benefits of market development and the related size of Volcano's addressable markets; our ability to project our intellectual property; dependence upon third parties; unexpected new data, safety and technical issues; market conditions and other risks inherent to medical and/or telecom device development and commercialization. These and additional risks and uncertainties are more fully described in Volcano's filings made with the Securities and Exchange Commission, including our 10-K for the year ended December 31, 2012, and other filings made with the Securities and Exchange Commission, which should be read in conjunction with these financial results. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano disclaims any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

  VOLCANO CORPORATION  CONDENSED CONSOLIDATED BALANCE SHEETS  (in thousands)  (unaudited)  March 31,  December 31, 20132012 Assets  Current assets:  Cash and cash equivalents 

$   276,315$
330,635 Short-term available-for-sale
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014 ... today announced that its subsidiary, Molecular Profiles Ltd., is ... at the annual CPhI/ICSE Worldwide event in ... companies with the rapid development of both standard and ... screening platform, which incorporates the company,s existing formulation and ...
(Date:10/1/2014)... ANTWERP, Belgium and NEW YORK , ... global Contract Research Organization (CRO) and service provider for the medical ... the opening of offices in New York City ... New York City is strategically centered in one of ... the East Coast", said Philippe Kassab , President at genae ...
(Date:10/1/2014)... Oct. 1, 2014 Trovagene, Inc., (NASDAQ: ... today that Eli Diamond , MD, Assistant ... (MSK), presented clinical data from an ongoing study ... platform for the determination of oncogene mutational status ... The results were presented to both treating physicians ...
Breaking Medicine Technology:Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 3Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 4
...  Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... progress in the development of ThermoVax™, its proprietary ... additional characterization of the stability of prototype vaccines ... excess of three months. These studies are being ...
... Medical, Inc. (OTCBB: AEMD), today released the following ... (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) The ... disease targets is to measure changes in patient viral ... is detectable in circulation.  Specific to Hepatitis C virus ...
Cached Medicine Technology:Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 2Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 3Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 4Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 5Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® 2Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® 3Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® 4
(Date:10/2/2014)... Thompson HealthDay Reporter ... pull out all the stops to rescue surgical patients ... the cost of such heroism is questionable, a new ... percent better at saving elderly patients with life-threatening complications ... less intensity, said senior author Dr. Amir Ghaferi. He ...
(Date:10/1/2014)... protein beta-amyloid is strongly associated with Alzheimer,s disease; however, ... peptide is the causal agent of the onset and ... confirmation is that beta-amyloid is not harmful when found ... when it self-assembles to form the so-called amyloid fibrils ... beta-amyloid alone, but with multiple ones because each aggregate ...
(Date:10/1/2014)... the Engineering and Physical Sciences Research Council (EPSRC) ... vital industrial control systems which run, for example, ... the rail network. , The research will ... malware infiltrating the systems behind our critical national ... Industrial Control Systems (RITICS), based at Imperial College ...
(Date:10/1/2014)... 2014 Familylifeinsurancequotes.org has released a ... for senior citizens. , Senior citizens can qualify ... sell coverage to seniors who are over 50 years ... without taking a medical examination. , Term life insurance ... senior clients can qualify. Having life insurance during retirement ...
(Date:10/1/2014)... 01, 2014 Lifeinsurance-policy.com has released ... best life insurance prices for smokers. , Smoking will ... premiums. Comparing quotes is the best method to find ... for customers who need coverage. , Whole life ... of the policy. Since the coverage is permanent, the ...
Breaking Medicine News(10 mins):Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2
... at the University of California, San Diego (UCSD) School ... healthy subjects //is associated with increased clotting of the ... disease. The findings were published in the March issue ... of Chest Physicians. ,'In previous work, we ...
... C. difficile, a bacterium commonly found in hospitals, is becoming ... April 2007 issue of Harvard Women’s Health Watch. Health experts ... to blame. ,Certain strains of C. difficile produce ... can cause symptoms ranging from mild diarrhea to severe colitis ...
... The burden of crystalline methamphetamine ("ice" or "crystal") ... is significant and set to grow, emergency physicians,and ... Journal of Australia (MJA), prompting an,urgent call to ... ,Two new studies have found that ...
... parties along with activists and film personalities have expressed ... and have vowed to fight it. ,Around ... malnutrition and half of them may die in the ... of Citizen Alliance, who are visiting the villages in ...
... plastic surgery in order to look more like a White ... is almost endemic in every group and ethnic community in ... acutely. , According to a survey by the ... getting plastic surgery quadrupled between 1997 and 2002. And in ...
... blast-related injury experts from eight countries that have ... emergency medical response to blast events and identified ... to enhance preparedness. The represented countries ... States, Spain, Saudi Arabia, and Turkey. The study ...
Cached Medicine News:Health News:Emergency Department Strain As Ice Problems Grows 2Health News:Emergency Department Strain As Ice Problems Grows 3Health News:MPs Vow to Fight Malnutrition in Madhya Pradesh 2Health News:Asians in US Increasingly Undergoing Plastic Surgery to Look White 2Health News:International Study Finds Ways to Maximize Effective Responses After Terrorism Incidents 2Health News:International Study Finds Ways to Maximize Effective Responses After Terrorism Incidents 3
Foldable Hydrophilic IOL with UV Absorber....
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
... Engineers at Pfizer used wavefront sensing ... Optic Technology. Innovative TECNIS features a patented ... spherical aberration, which compensates for the positive ... result, TECNIS is the first and only ...
... PhacoFlexII SI30NB is foldable silicone ... it's patients. It is used ... SI30NB is indicated for primary ... of aphakia in adults (over ...
Medicine Products: